BIO-TECHNE Corp (TECH) Options Risk Score
Real-time risk analysis for TECH options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full TECH options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan TECH Now — Free →
Is it risky to sell options on BIO-TECHNE Corp (TECH) right now?
For a 4-week expiry, BIO-TECHNE Corp (TECH) carries an options catalyst-risk score of 100 out of 100 (HIGH). What pushes it there: 3 recent news items, 10 active legal filings and 16 clinical-trial catalysts, all landing inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on TECH is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
TECH shows an IV Rank of 100 — implied volatility is near the top of its own one-year range, so TECH options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 172%. IV Rank is the most useful figure for deciding whether to sell or buy premium on TECH.
TECH does not report again until 2026-08-05, so near-dated expiries avoid it.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer